Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Radiotherapy With Novel Technologies and Strategies for Refractory Brain Metastases: A Multicenter Prospective Study

NCT07586657 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT07586657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07586657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Radiotherapy With Novel Technologies and Strategies for Refractory Brain Metastases: A Multicenter Prospective Study
Lead sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 28, 2026
Completion date
December 31, 2028
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasases